RAPT Therapeutics, Inc. (RAPT)
NASDAQ: RAPT · Real-Time Price · USD
29.44
+0.42 (1.45%)
At close: Oct 8, 2025, 4:00 PM EDT
30.02
+0.58 (1.97%)
After-hours: Oct 8, 2025, 4:29 PM EDT

RAPT Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
4872138556721,085485
Upgrade
Market Cap Growth
679.28%-75.05%27.19%-38.08%123.77%-19.54%
Upgrade
Enterprise Value
328120677484874362
Upgrade
Last Close Price
29.0212.64198.80158.40293.84158.00
Upgrade
PS Ratio
---440.09284.6196.19
Upgrade
PB Ratio
2.921.125.812.745.824.66
Upgrade
P/TBV Ratio
3.001.125.812.745.824.66
Upgrade
EV/Sales Ratio
---317.25229.3371.83
Upgrade
Debt / Equity Ratio
0.020.020.050.04--
Upgrade
Asset Turnover
---0.010.020.05
Upgrade
Quick Ratio
12.954.787.2817.5119.779.50
Upgrade
Current Ratio
13.254.877.4117.7720.119.85
Upgrade
Return on Equity (ROE)
-77.83%-77.09%-59.56%-38.86%-47.63%-59.66%
Upgrade
Return on Assets (ROA)
-46.24%-41.13%-36.13%-23.07%-27.24%-32.67%
Upgrade
Return on Capital (ROIC)
-50.02%-48.84%-38.92%-24.34%-29.77%-37.52%
Upgrade
Earnings Yield
-21.56%-60.90%-13.66%-12.48%-6.38%-10.91%
Upgrade
FCF Yield
-18.59%-39.12%-11.49%-10.66%-5.69%-8.43%
Upgrade
Buyback Yield / Dilution
-234.91%-6.32%-17.82%-18.80%-13.49%-455.27%
Upgrade
Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q